Chapter 5.4 Memory and cognitive performance in preclinical Alzheimer's disease and preclinical vascular disease

Handbook of Behavioral Neuroscience

Volumn 18, Issue , 2008, Pages 537-551

  Small, Brent J ^a,b,c   MacDonald, Stuart W S ^d,e   Iser, Lindsay ^a   Bäckman, Lars ^e  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Research Institute   (United States)

^d UNIVERSITY OF VICTORIA   (Canada)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; detection of dementia; vascular dementia

Indexed keywords

EID: 67649782457     PISSN: 15697339     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-7339(08)00229-4     Document Type: Review

References (89)

1. Almkvist O., Fratiglioni L., Aguero-Torres H., Viitanen M., and Bäckman L. Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients. J. Clin. Exp. Neuropsychol. 21 (1999) 816-830
2. Amieva H., Jacqmin-Gadda H., Orgogozo J.M., Le Carret N., Helmer C., Letenneur L., et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 128 (2005) 1093-1101
3. Bäckman L., Jones S., Berger A.K., Laukka E.J., and Small B.J. Multiple cognitive deficits during the transition to Alzheimer's disease. J. Intern. Med. 256 3 (2004) 195-204
4. Bäckman L., Jones S., Berger A.-K., Laukka E.J., and Small B.J. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 19 4 (2005) 520-531
5. Bäckman L., Jones S., Small B.J., Aguero-Torres H., and Fratiglioni L. Rate of cognitive decline in preclinical Alzheimer's disease: the role of comorbidity. J. Gerontol. B: Psychol. Sci. Soc. Sci. 58B 4 (2003) P228-P236
6. Bäckman L., and Small B.J. Influences of cognitive support on episodic remembering: tracing the process of loss from normal aging to Alzheimer's disease. Psychol. Aging 13 2 (1998) 267-276
7. Bäckman L., Small B.J., and Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain: J. Neurol. 124 1 (2001) 96-102
8. Bäckman L., Small B.J., and Wahlin A. Aging and memory: cognitive and biological perspectives. In: Birren J.E., and Schaie K.W. (Eds). Handbook of the Psychology of Aging. 5 edn. (2001), Academic Press, San Diego, CA 349-377
9. Berger A.K., Fratiglioni L., Forsell Y., Winblad B., and Bäckman L. The occurence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 53 (1999) 1998-2002
10. Braak H., and Braak E. Staging of Alzheimer disease-related neurofibrillary tangles. Neurobiol. Aging 16 (1995) 271-284
11. Brookmeyer R., Gray S., and Kawas C.H. Projections of Alzheimer' disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 88 (1998) 1337-1342
12. Buckner R.L., and Wheeler M.E. The cognitive neuroscience of remembering. Nat. Rev. Neurosci. 2 (2001) 624-634
13. Chen P.J., Ratcliff G., Belle S.H., Cauley J.A., DeKosky S.T., and Ganguli M. Patterns of cognitive decline in presymptomatic Alzheimer disease - a prospective community study. Arch. Gen. Psychiatry 58 9 (2001) 853-858
14. Crowe M., Andel R., Pedersen N.L., Johansson B., and Gatz M. Does participation in leisure activities lead to reduced risk of Alzheimer's disease? A prospective study of Swedish twins. J. Gerontol. B Psychol. Sci. Soc. Sci. 58 5 (2003) P249-P255
15. Daly E., Zaitchik D., Copeland M., Schmahmann J., Gunther J., and Albert M. Predicting conversion to Alzheimer disease using standardized clinical information. Arch. Neurol. 57 (2000) 675-680
16. DeKosky S.T. Early intervention is key to successful management of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 17 (2003) S99-S104
17. Elias M.F., Beiser A., Wolf H., Au R., White R.F., and D'Agostino R.B. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch. Neurol. 57 (2000) 808-813
18. Fahlander K., Wahlin A., Almkvist O., and Bäckman L. Cognitive functioning in Alzheimer's disease and vascular dementia: further evidence for similar patterns of evidence. J. Clin. Exp. Neuropsychol. 24 (2002) 734-744
19. Farrer L.A., Cupples L.A., Haines J.L., Hyman B.T., Kukull W.A., Mayeux R., et al. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and Alzheimer disease: a meta-analysis. J. Am. Med. Assoc. 278 (1997) 1349-1356
20. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005) 2112-2117
21. Fox N.C., Warrington E.K., Freeborough P.A., Hartikainen P., Kennedy A.M., Stevens J.M., et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. Brain 119 (1996) 2001-2007
22. Fratiglioni L., Paillard-Borg S., and Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 3 6 (2004) 343-353
23. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., and Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48 (1997) 132-138
24. Hall C.B., Derby C., LeValley A., Katz M.J., Verghese J., and Lipton R.B. Education delays accelerated decline on a memory test in persons who develop dementia. Neurology 69 (2007) 1657-1664
25. Hassing L., and Bäckman L. Episodic memory functioning in population-based samples of very old adults with Alzheimer's disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 8 (1997) 376-383
26. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60 (2003) 1119-1122
27. Huang J., and Auchus A.P. Diffusion tensor imaging of normal appearing white matter and its correlation with cognitive functioning in mild cognitive impairment and Alzheimer's disease. Ann. N.Y. Acad. Sci. 1097 (2007) 259-264
28. Hultsch D.F., Hertzog C., Dixon R.A., and Small B.J. Memory change in the aged (1998), Cambridge University Press, Cambridge
29. Ingles J.L., Wentzel C., Fisk J.D., and Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without stroke. Stroke 33 (2002) 1999-2002
30. Jagust W.J., Gitcho A., Sun F., Kuczynski B., Mungas D., and Haan M.N. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann. Neurol. 59 (2006) 673-681
31. Jones S., Laukka E.J., and Bäckman L. Differential verbal fluency deficits in the preclinical stages of Alzheimer's disease and vascular dementia. Cortex 42 (2006) 347-355
32. Jones S., Laukka E.J., Small B.J., Fratiglioni L., and Bäckman L. A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis. Dement. Geriatr. Cogn. Disord. 18 3-4 (2004) 233-239
33. Jorm A.F., Masaki K.H., Petrovitch H., Ross G.W., and White L.R. Cognitive deficits 3 to 6 years before dementia onset in a population sample: the Honolulu-Asia aging study. J. Am. Geriatr. Soc. 53 3 (2005) 452-455
34. Klunk W.E. Biological markers of Alzheimer's disease. Neurobiol. Aging 19 (1998) 145-147
35. Kogure D., Matsuda H., Ohnishi T., Asada T., Uno M., Kunihiro T., et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J. Nucl. Med. 41 7 (2000) 1155-1162
36. Kramer A.F., Bherer L., Colcombe S.J., Dong W., and Greenough W.T. Environmental influences on cognitive and brain plasticity during aging. J. Gerontol. A Biol. Sci. Med. Sci. 59 9 (2004) 940-957
37. Kramer J.H., Reed B.R., Mungas D., Weiner M.W., and Chui H.C. Executive dysfunction in subcortical ischaemic vascular disease. J. Neurol. Neurosurg. Psychiatry 72 (2002) 217-220
38. Langa K.M., Foster N.L., and Larson E.B. Mixed dementia: emerging concepts and therapeutic implications. J. Am. Med. Assoc. 292 (2004) 2901-2908
39. Langa K.M., Plassman B.L., Wallace R.B., Herzog A.R., Heerings S.G., Ofstedal M.B., et al. The aging, demographics, and memory study: study design and methods. Neuroepidemiology 25 (2005) 181-191
40. Lange K.L., Bondi M.W., Salmon D.P., Galasko D., Delis D.C., Thomas R.G., et al. Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype. J. Int. Neuropsychol. Soc. 8 7 (2002) 943-955
41. Laukka E.J., Jones S., Fratiglioni L., and Bäckman L. Cognitive functioning in preclinical vascular dementia: a 6-year follow-up. Stroke 35 (2004) 1805-1809
42. Laukka E.J., Jones S., Small B.J., Fratiglioni L., and Bäckman L. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease. J. Int. Neuropsychol. Soc. 10 3 (2004) 382-391
43. Laukka, E.J., Karlsson, S., MacDonald, S.W.S. and Bäckman, L. (in press) Cognitive functioning in vascular dementia before and after diagnosis. In: Wahlund, L.O., Erkinjuntti, T. and Gauthier, S. (Eds.), Treatment of Vascular Dementia. Cambridge University Press, Cambridge.
44. Lutz W., Sanderson W., and Scherbov S. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease. J. Int. Neuropsychol. Soc. 451 (2008) 716-719
45. MacDonald S.W.S., Nyberg L., Sandblom J., Fischer H., and Bäckman L. Increased response-time variability is associated with reduced inferior parietal activation in recognition memory in aging. J. Cogn. Neurosci. 20 (2007) 779-786
46. MacDonald, S.W.S., Thorvaldsson, V., Johansson, B. and Bäckman, L. (2007) Change-point patterns of cognitive decline in preclinical dementia: findings from the Kungsholmen and H70 Projects. Paper presented at the Gerontological Society of America, San Francisco, CA.
47. Mann D.M. Pathological correlates of dementia in Alzheimer's disease. Neurobiol. Aging 15 (1994) 357-360
48. Markesbery W.R., Schmitt F.A., Kryscio R.J., Davis C.D., and Wekstein D.R. Neuropathologic substrate of mild cognitive impairment. Arch. Neurol. 63 (2006) 38-46
49. Meyer J.S., Xu G., Thornby J., Chowdhury M., and Quach M. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease?. Stroke 33 (2002) 1981-1985
50. Meyer J.S., Xu G.L., Thornby J., Chowdhury M., and Quach M. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J. Neurol. Sci. 201 1-2 (2002) 19-25
51. Nyberg L., McIntosh A.R., Houle S., Nilsson L.G., and Tulving E. Activation of medial temporal structures during episodic memory retrieval. Nature 380 (1996) 715-717
52. Palmer K., Bäckman L., Winblad B., and Fratiglioni L. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. Br. Med. J. 326 7383 (2003) 245-247
53. Petersen R.C., Thomas R.G., Grundman M., Bennett D.A., Doody R., Ferris S., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 325 23 (2005) 2379-2388
54. Pihlajamaki M., Tanila H., Hanninen T., Kononen M., Laakso M., Partanen K., et al. Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann. Neurol. 47 (2000) 470-476
55. Plassman B.L., Langa K.M., Fisher G.G., Heerings S.G., Weir D.R., Ofstedal M.B., et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29 (2007) 125-132
56. Prince M., Acosta D., Chiu H., Scazufca M., and Varghese M. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 361 (2003) 909-917
57. Rentz D.M., Huh T.J., Faust R.R., Budson A.E., Scinto L.F.M., Sperling R.A., et al. Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology 18 1 (2004) 38-49
58. Rinder L., Roupe S., Steen B., and Svanborg A. Seventy-year-old people in Gotheburg: a population study. Acta Med. Scand. 198 (1975) 397-407
59. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDC-AIREN international workshop. Neurology 43 (1993) 250-260
60. Rovio S., Kareholt I., Helkala E.-L., Viitanen M., Winblad B., Tuomilehto J., et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 4 11 (2005) 705-711
61. 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 7 (2008) 129-135
62. Rowe C.C., Ng S., Ackermann U., Gong S.J., Pike K., Savage G., et al. Imaging B-amyloid burden in aging and dementia. Neurology 68 (2007) 1718-1725
63. Sacuiu S., Sjogren M., Johansson B., Gustafson D., and Skoog I. Prodromal cognitive signs of dementia in 85-year-olds using four sources of information. Neurology 65 (2005) 1894-1900
64. Silverman D.H.S., Small G.W., Chang C.Y., Lu C.S., de Aburto M.A.K., Chen W., et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 286 17 (2001) 2120-2127
65. Simon E., Leach L., Winocur G., and Moscovitch M. Intact primary memory in mild to moderate Alzheimer′s disease: indices from the California verbal learning test. J. Clin. Exp. Neuropsychol. 16 (1995) 414-422
66. Simons J.S., and Spiers H.J. Prefrontal and medial temporal lobe interactions in long-term memory. Nat. Rev. Neurosci. 4 (2003) 637-648
67. Skoog I., Nilsson L., Palmertz B., Andreasson L.A., and Svanborg A. A population-based study of dementia in 85-year-olds. N. Engl. J. Med. 328 (1993) 153-158
68. Small B.J., Fratiglioni L., Viitanen M., Winblad B., and Bäckman L. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch. Neurol. 57 6 (2000) 839-844
69. Small B.J., Herlitz A., Fratiglioni L., Almkvist O., and Bäckman L. Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology 11 3 (1997) 413-420
70. Small B.J., Rosnick C.B., Fratiglioni L., and Bäckman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol. Aging 19 4 (2004) 592-600
71. Small S.A., Perara G., DeLaPaz R., Mayeux R., and Stern Y. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann. Neurol. 45 (1999) 466-472
72. Smith G.E., Pankratz V.S., Negash S., Machulda M.M., Petersen R.C., Boeve B., et al. A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms?. Neurology 69 (2007) 133-139
73. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 8 3 (2002) 448-460
74. In: Stern Y. (Ed). Cognitive Reserve: Theory and Applications (2007), Taylor and Francis, New York, NY
75. Stern Y., Tang M.X., Denaro J., and Mayeux R. Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann. Neurol. 37 (1995) 590-595
76. Storandt M., Grant E.A., Miller J.P., and Morris J.C. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 59 7 (2002) 1034-1041
77. Takahashia H., Katob M., Hayashib M., Okuboc Y., Takanoa A., Itoa H., et al. Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus. Neuroimage 34 (2007) 1643-1649
78. Thorvaldsson, V., MacDonald, S.W.S., Skoog, I., Bäckman, L. and Johansson, B. (2008) Acceleration in cognitive decline in preclinical dementia: findings from two Swedish population-based longitudinal studies. Manuscript submitted for publication.
79. Tierney M.C., Szalai J.P., Dunn E., Geslani D., and McDowell I. Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment. Arch. Family Med. 9 (2000) 527-532
80. Van Der Flier W.M., Van Den Heuvel D.M.J., Weverling-Rijnsburger A.W.E., Bollen E.L.E.M., Westendorp R.G.J., Van Buchem M.A., et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann. Neurol. 52 1 (2002) 62-67
81. Vargha-Khadem F., Gadian D.G., Watkins K.E., Connelly W., Van Paesschen W., and Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory. Science 277 (1997) 376-380
82. Wagner A.D., Shannon B.J., Kahn I., and Buckner R.L. Parietal lobe contributions to episodic memory retrieval. Trends Cogn. Sci. 9 (2005) 445-453
83. Wiesje M., Van Der Flier D.M.J., Van Den Heuvel A.W.E., Weverling-Rijnsburger E.E.M., Bollen R.G.J., Westendorp M.A., et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann. Neurol. 52 1 (2002) 62-67
84. Wilson R.S., and Bennett D.A. Cognitive activity and risk of Alzheimer's disease. Curr. Dir. Psychol. Sci. 12 3 (2003) 87-91
85. Wilson R.S., Bennett D.A., de Leon C.F.M., Bienias J.L., Morris M.C., and Evans D.A. Distress proneness and cognitive decline in a population of older persons. Psychoneuroendocrinology 30 1 (2005) 11-17
86. Wilson R.S., Evans D.A., Bienias J.L., de Leon C.F.M., Schneider J.A., and Bennett D.A. Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology 61 11 (2003) 1479-1485
87. Wilson R.S., Gilley D.W., Bennett D.A., Beckett L.A., and Evans D.A. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol. Aging 15 (2000) 18-28
88. Winblad B., Kilander L., Eriksson S., Minthon L., Båtsman S., Wetterholm A.-L., et al. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet 367 (2006) 1057-1065
89. Yoshita M., Fletcher E., Harvey D., Ortega M., Martinez O., Mungas D.M., et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 67 12 (2006) 2192-2198